[利用培养的同基因荷瘤小鼠脾细胞对小鼠肿瘤进行过继免疫治疗。II：培养淋巴细胞对恶性腹水的治疗作用及其被链球菌制剂OK 432增强的效果] - Suppr | 超能文献

[Adoptive immunotherapy of murine tumors using cultured syngeneic tumor-bearer-spleen cells. II: Therapeutic effect of cultured lymphocytes against malignant ascites and its augmentation by the streptococcal preparation, OK 432].

作者信息

Kan N, Inamoto T, Hori T, Nio Y, Tsuchitani T, Kodama H, Tobe T, Ohgaki K

出版信息

Nihon Gan Chiryo Gakkai Shi. 1985 May 20;20(4):784-96.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Adoptive immunotherapy of murine tumors using cultured syngeneic tumor-bearer-spleen cells. II: Therapeutic effect of cultured lymphocytes against malignant ascites and its augmentation by the streptococcal preparation, OK 432].[利用培养的同基因荷瘤小鼠脾细胞对小鼠肿瘤进行过继免疫治疗。II：培养淋巴细胞对恶性腹水的治疗作用及其被链球菌制剂OK 432增强的效果]

Nihon Gan Chiryo Gakkai Shi. 1985 May 20;20(4):784-96.

2

[Effect of combined immunotherapy using two different BRMs; OK-432 and IL-2-cultured lymphocytes].[使用两种不同生物反应调节剂（OK-432和白细胞介素-2培养淋巴细胞）联合免疫疗法的效果]

Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 2):1298-306.

3

Adoptive immunotherapy in tumor-bearing mice with OK-432-induced killer cells.用OK-432诱导的杀伤细胞对荷瘤小鼠进行过继性免疫治疗。

Jpn J Exp Med. 1988 Apr;58(2):109-14.

4

Therapeutic efficacy of sequential therapy with OK-432, cyclophosphamide, IL2-cultured lymphocytes and in vivo IL2 against advanced murine plasmacytoma.OK-432、环磷酰胺、白细胞介素2培养淋巴细胞及体内白细胞介素2序贯治疗晚期小鼠浆细胞瘤的疗效

Biotherapy. 1989;1(3):197-206. doi: 10.1007/BF02170888.

5

[Adoptive immunotherapy of murine tumor using cultured syngeneic tumor-bearer-spleen cells. 1: Anti-tumor activity of tumor-bearer-spleen cells cultured with T cell growth factor (TCGF) and soluble tumor extract].[利用培养的同基因荷瘤小鼠脾细胞进行小鼠肿瘤的过继性免疫治疗。1：用T细胞生长因子（TCGF）和可溶性肿瘤提取物培养的荷瘤小鼠脾细胞的抗肿瘤活性]

Nihon Gan Chiryo Gakkai Shi. 1985 Feb 20;20(1):31-9.

6

[Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect].[过继免疫疗法联合OK-432预先给药增强治疗效果的实验与临床研究]

Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-2):1455-61.

7

[Experimental study on the antitumor activity of regional lymph nodes during immunotherapy].[免疫治疗期间区域淋巴结抗肿瘤活性的实验研究]

Nihon Geka Gakkai Zasshi. 1984 Nov;85(11):1479-89.

8

[A study of the synergy of microwave coagulation and streptococcal preparation (OK-432) in experimental tumors in relation to interleukin 2 producing activity].[关于微波凝固与链球菌制剂（沙培林）在实验性肿瘤中协同作用与白细胞介素2产生活性关系的研究]

Nihon Geka Hokan. 1986 Sep 1;55(5):689-99.

9

Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.OK-432与α-干扰素或γ-干扰素联合治疗对BALB/c小鼠Meth-A腹水瘤的协同治疗作用。

J Biol Response Mod. 1988 Aug;7(4):371-83.

10

Splenectomy abolishes antitumor effect of immunotherapy with streptococcal preparation, OK-432, on mouse liver tumors.脾切除术消除了用链球菌制剂OK-432对小鼠肝肿瘤进行免疫治疗的抗肿瘤作用。

Anticancer Res. 1991 May-Jun;11(3):1269-74.

引用本文的文献

1

In vivo and in vitro synergistic antitumor effect of interleukin-2-cultured tumor-bearer spleen cells and immune fresh spleen cells.白细胞介素-2培养的荷瘤脾细胞与免疫新鲜脾细胞的体内外协同抗肿瘤作用

Cancer Immunol Immunother. 1989;28(4):260-6. doi: 10.1007/BF00205235.

2

A murine plasmacytoma MOPC 104E resistant to cyclophosphamide is resistant to immunotherapy.对环磷酰胺耐药的小鼠浆细胞瘤MOPC 104E对免疫疗法也耐药。

Cancer Immunol Immunother. 1991;32(5):273-9. doi: 10.1007/BF01789044.